Skip to main content
. 2021 Jul 10;5(11):1873–1887. doi: 10.1002/hep4.1767

FIG. 3.

FIG. 3

Antiviral responses during TDF monotherapy in the REP 401 study. HBsAg IC decline during TDF monotherapy (A) was statistically significant and universal except for participants 01‐042 and 02‐003. Increases in declines in HBV DNA, HBV RNA, and HBcrAg were significantly greater than for HBsAg (B).